Skip to content
  • Monday, 21 September 2026
  • 1:58 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Telix Pharmaceuticals Agrees to Acquire ITM Isotope Technologies Munich in Landmark $2.35bn Radiopharmaceutical Megamerger
Pharmaceutical R&D

Telix Pharmaceuticals Agrees to Acquire ITM Isotope Technologies Munich in Landmark $2.35bn Radiopharmaceutical Megamerger

Teuku Ryan Sep 21, 2026 0

Australia-based radiopharmaceutical leader Telix Pharmaceuticals has entered into a definitive agreement to acquire Germany’s ITM Isotope Technologies Munich in a…

Read More
Unlocking Deep Time: Ancient Regulatory DNA Reveals Secrets of Plant EvolutionScience News: A Centennial of Empowering Public Understanding of ScienceGenes offer new clues to stopping Huntington’s disease in its tracksFive Essential Approaches to Robust Outlier Detection in Modern Data Analysis
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Decoding the Explosive Origins of Chronic Myeloid Leukemia: A Landmark Study Unveils Unprecedented Cancer Cell Growth Rates Years Before DiagnosisBreaking the Neuroimaging Time Barrier: Johns Hopkins Researchers Unveil CloudScope to Monitor Brain Disease Over 24 HoursArtificial Intelligence Framework PACMAN Revolutionizes Nuclear Fusion Control by Subduing Millisecond Plasma InstabilitiesTelix Pharmaceuticals Agrees to Acquire ITM Isotope Technologies Munich in Landmark $2.35bn Radiopharmaceutical Megamerger
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Decoding the Explosive Origins of Chronic Myeloid Leukemia: A Landmark Study Unveils Unprecedented Cancer Cell Growth Rates Years Before Diagnosis
Dwi Wanna Sep 21, 2026
Biotech & Genetic Research
Breaking the Neuroimaging Time Barrier: Johns Hopkins Researchers Unveil CloudScope to Monitor Brain Disease Over 24 Hours
Jia Lissa Sep 21, 2026
Advanced Materials Science
Artificial Intelligence Framework PACMAN Revolutionizes Nuclear Fusion Control by Subduing Millisecond Plasma Instabilities
Nila Kartika Wati Sep 21, 2026
Pharmaceutical R&D
Telix Pharmaceuticals Agrees to Acquire ITM Isotope Technologies Munich in Landmark $2.35bn Radiopharmaceutical Megamerger
Teuku Ryan Sep 21, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ